Submaximal exercise metrics: Looking prior to VO₂max : in Heart Failure.

IF 5.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Panagiota Georgiadou, Αthanasios Dritsas
{"title":"Submaximal exercise metrics: Looking prior to VO₂max : in Heart Failure.","authors":"Panagiota Georgiadou, Αthanasios Dritsas","doi":"10.1007/s10741-026-10606-6","DOIUrl":null,"url":null,"abstract":"<p><p>Maximal oxygen uptake (VO₂max) remains the benchmark for cardiopulmonary exercise testing (CPET) in chronic heart failure (CHF). However, VO₂max and its surrogate, VO₂peak, often fail to capture the full spectrum of functional impairment, especially in patients unable to reach maximal effort. This review delineates submaximal CPET-derived metrics that offer valuable prognostic and diagnostic insights beyond VO₂max and are less dependent on peak effort. Guideline-endorsed parameters such as ventilatory anaerobic threshold (VAT) and the minute ventilation–carbon dioxide production slope (VE/VCO₂) are established tools for risk stratification and transplant evaluation. Emerging markers—including O₂ uptake efficiency slope (OUES), exertional oscillatory ventilation (EOV), O₂ pulse and cardiorespiratory optimal point (COP)—offer robust prognostic value in effort-limited populations. Additionally, O₂ uptake kinetics and extrapolated maximal oxygen consumption (EMOC) provide mechanistic perspectives on central and peripheral limitations, though their clinical integration remains early. Incorporating these submaximal metrics into composite risk models may enhance individualized care and improve outcomes in CHF.</p>","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":"31 1","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Failure Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10741-026-10606-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Maximal oxygen uptake (VO₂max) remains the benchmark for cardiopulmonary exercise testing (CPET) in chronic heart failure (CHF). However, VO₂max and its surrogate, VO₂peak, often fail to capture the full spectrum of functional impairment, especially in patients unable to reach maximal effort. This review delineates submaximal CPET-derived metrics that offer valuable prognostic and diagnostic insights beyond VO₂max and are less dependent on peak effort. Guideline-endorsed parameters such as ventilatory anaerobic threshold (VAT) and the minute ventilation–carbon dioxide production slope (VE/VCO₂) are established tools for risk stratification and transplant evaluation. Emerging markers—including O₂ uptake efficiency slope (OUES), exertional oscillatory ventilation (EOV), O₂ pulse and cardiorespiratory optimal point (COP)—offer robust prognostic value in effort-limited populations. Additionally, O₂ uptake kinetics and extrapolated maximal oxygen consumption (EMOC) provide mechanistic perspectives on central and peripheral limitations, though their clinical integration remains early. Incorporating these submaximal metrics into composite risk models may enhance individualized care and improve outcomes in CHF.

次最大运动指标:在心力衰竭中VO 2 max之前的观察。
最大摄氧量(vo2max)仍然是慢性心力衰竭(CHF)心肺运动测试(CPET)的基准。然而,vo2 max及其替代物vo2 peak往往不能反映功能损害的全部情况,特别是在无法达到最大努力的患者中。本综述描述了次最大cpet衍生指标,这些指标提供了有价值的预后和诊断见解,超出了vo2max,并且较少依赖于峰值努力。指南认可的参数,如通气厌氧阈值(VAT)和微小通气-二氧化碳产生斜率(VE/VCO 2)是风险分层和移植评估的既定工具。新兴的指标——包括O₂吸收效率斜率(OUES)、用力振荡通气(EOV)、O₂脉冲和心肺最佳点(COP)——在努力受限的人群中提供了强大的预后价值。此外,O₂摄取动力学和外推最大耗氧量(EMOC)为中枢和外周局限性提供了机制视角,尽管它们的临床整合仍处于早期阶段。将这些次极大指标纳入综合风险模型可以加强个体化护理并改善CHF的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart Failure Reviews
Heart Failure Reviews 医学-心血管系统
CiteScore
10.40
自引率
2.20%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Heart Failure Reviews is an international journal which develops links between basic scientists and clinical investigators, creating a unique, interdisciplinary dialogue focused on heart failure, its pathogenesis and treatment. The journal accordingly publishes papers in both basic and clinical research fields. Topics covered include clinical and surgical approaches to therapy, basic pharmacology, biochemistry, molecular biology, pathology, and electrophysiology. The reviews are comprehensive, expanding the reader''s knowledge base and awareness of current research and new findings in this rapidly growing field of cardiovascular medicine. All reviews are thoroughly peer-reviewed before publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书